|
Press Releases
| |
2005
|
Displaying releases:
1-15 | 16-30 | 31-39
|
| |
Dec-19-2005
|
Palatin Technologies, Inc. Announces Voluntary Suspension of Sales, Marketing and Distribution of NeutroSpec(R)
|
| |
Dec-09-2005
|
Palatin Technologies to Present at the JP Morgan 24th Annual Healthcare Conference
|
| |
Dec-02-2005
|
Palatin Technologies, Inc. Announces Issuance of Communication to Healthcare Providers Concerning NeutroSpec
|
| |
Nov-29-2005
|
Palatin Technologies to Present at the Lazard Capital Markets Annual Life Sciences Conference
|
| |
Nov-08-2005
|
Palatin Technologies, Inc. Reports Fiscal Year 2006 First Quarter Results; Teleconference and Webcast Being Held Today at 10:00 a.m. EST
|
| |
Nov-03-2005
|
Palatin Technologies to Report First Quarter, Fiscal Year 2006 Financial Results; Teleconference and Webcast on November 8th
|
| |
Oct-31-2005
|
Palatin Technologies to Present at Two Investor Conferences in November 2005
|
| |
Oct-14-2005
|
Palatin Technologies to Present at the 2005 BIO InvestorForum
|
| |
Sep-27-2005
|
Palatin Technologies, Inc. Receives $10 Million Payment From King Pharmaceuticals, Inc.
|
| |
Sep-26-2005
|
Palatin Technologies to Present at the UBS Global Life Sciences Conference
|
| |
Sep-20-2005
|
J. Stanley Hull Joins Palatin Technologies, Inc. Board of Directors
|
| |
Sep-14-2005
|
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2005 Results; Teleconference and Webcast Being held Today at 10:00 a.m. EDT
|
| |
Sep-09-2005
|
Palatin Technologies, Inc. to Report Fourth Quarter, Fiscal Year 2005 Financial Results & Host Teleconference and Webcast on September 14, 2005
|
| |
Aug-30-2005
|
Palatin Technologies to Present at the Thomas Weisel Partners 2005 Healthcare Conference
|
| |
Aug-03-2005
|
King Pharmaceuticals and Palatin Technologies Initiate Phase IIb Clinical Trials Evaluating PT-141 in Patients Suffering from Erectile Dysfunction
|
| |
 |
|
|
